Clinical and serological characterization of acute pleuropericarditis suggests an autoinflammatory pathogenesis and highlights risk factors for recurrent attacks
Dorothee Kaudewitz(Innsbruck Medical University), Norbert Blank, Jan Meis, Lukas John(University of Hohenheim), Florian Leuschner(Heidelberg University), Hanns‐Martin Lorenz, Norbert Frey(Heidelberg University)
Cited by 4
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k
Therapeutic siRNA silencing in inflammatory monocytes in mice
|Nature Biotechnology|2011|837
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis
|The Journal of Experimental Medicine|2012|535